|
DDC
| 615 | |
Tác giả CN
| Nguyễn, Quỳnh Hoa | |
Nhan đề
| Phân tích cơ cấu thuốc điều trị ung thư sử dụng tại Bệnh viện K năm 2016 / Nguyễn Quỳnh Hoa, Nguyễn Trung Hà, Nguyễn Sơn Nam | |
Tóm tắt
| Due to the efficacy of chemotherapy in combination with surgery and radiotherapy in treatment of many types of cancer, the expense for antineoplastic agents at the National Cancer Hospital has been increasing over the recent years, to improve the effectiveness, the structure of antineoplastic agents in use therein was analysed by therapeutic analysis and ABC analysis. Evidently, phytochemical alcaloids and other natural products made up the highest percentage of expenditure (122.96 billion VND, accounting for 26.74% of the total 459.96 billion VND), followed by the target group including monoclonal antibodies (19.7%, eq. 90.6 billion VND) and proteinkinase inhibitor (15.6%, eq. 71.6 billion VND). The percentage of domestic drugs was so low as 1.92%, whereas that of brand name drugs were 60 % of total expenditure for antineoplatic agents. Group A drugs including 10 activities accounted for 76.86% of the total cost; and of these, paclitaxel was in the highest proportion (21.05%). Group B accounted for 17.21% of the medicine cost, including 7 drugs; and including 15 drugs, group C accounted for 5.93 %. | |
Thuật ngữ chủ đề
| Nghiên cứu - Kỹ thuật --Việt Nam | |
Từ khóa tự do
| Ung thư | |
Từ khóa tự do
| Bệnh viện K | |
Tác giả(bs) CN
| Nguyễn, Trung Hà | |
Nguồn trích
| Tạp chí Dược học 2018tr. 12-16
Số: 02 |
| |
000
| 00000nab#a2200000ui#4500 |
|---|
| 001 | 18900 |
|---|
| 002 | 9 |
|---|
| 004 | 7D956097-BB92-4952-B9FD-87A1D8051167 |
|---|
| 005 | 201912131119 |
|---|
| 008 | 081223s vm| vie |
|---|
| 009 | 1 0 |
|---|
| 039 | |y20191213111908|zthienvan |
|---|
| 082 | |a615 |
|---|
| 100 | |aNguyễn, Quỳnh Hoa |
|---|
| 245 | |aPhân tích cơ cấu thuốc điều trị ung thư sử dụng tại Bệnh viện K năm 2016 / |cNguyễn Quỳnh Hoa, Nguyễn Trung Hà, Nguyễn Sơn Nam |
|---|
| 520 | |aDue to the efficacy of chemotherapy in combination with surgery and radiotherapy in treatment of many types of cancer, the expense for antineoplastic agents at the National Cancer Hospital has been increasing over the recent years, to improve the effectiveness, the structure of antineoplastic agents in use therein was analysed by therapeutic analysis and ABC analysis. Evidently, phytochemical alcaloids and other natural products made up the highest percentage of expenditure (122.96 billion VND, accounting for 26.74% of the total 459.96 billion VND), followed by the target group including monoclonal antibodies (19.7%, eq. 90.6 billion VND) and proteinkinase inhibitor (15.6%, eq. 71.6 billion VND). The percentage of domestic drugs was so low as 1.92%, whereas that of brand name drugs were 60 % of total expenditure for antineoplatic agents. Group A drugs including 10 activities accounted for 76.86% of the total cost; and of these, paclitaxel was in the highest proportion (21.05%). Group B accounted for 17.21% of the medicine cost, including 7 drugs; and including 15 drugs, group C accounted for 5.93 %. |
|---|
| 650 | |aNghiên cứu - Kỹ thuật |zViệt Nam |
|---|
| 653 | |aUng thư |
|---|
| 653 | |aBệnh viện K |
|---|
| 700 | |aNguyễn, Trung Hà |
|---|
| 773 | |tTạp chí Dược học |d2018|gtr. 12-16|i02 |
|---|
| 890 | |c1|a0|b0|d3 |
|---|
| |
Không tìm thấy biểu ghi nào
|
|
|
|